October 3, 2022
Loading...
You are here:  Home  >  Top Stories  >  Top Story  >  Current Article

MannKind shifts to marketing inhaler technology

IN THIS ARTICLE

Biopharmaceutical MannKind, which has its headquarters in Westlake Village, is positioning itself as a med-tech platform. (Courtesy photo) MannKind has once again disappointed its short-sellers after news of a $105 million licensing deal with Maryland-based United Therapeutics sent shares soaring more than 140 percent. MannKind announced the deal just weeks from tripping over a $20…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.